Involvement of heparanase in the pathogenesis of acute pancreatitis: Implication of novel therapeutic approaches
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Dalit B Hamo-Giladi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, The Ruth & Bruce Rappaport Faculty of Medicine, Haifa, Israel. Hauptthemen laut MEDLINE: Pancreatitis, Glucuronidase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Gastroenterology Association; and Kamin.
Abstract (Originalsprache)
Acute pancreatitis (AP) is a common gastrointestinal disease with high morbidity and mortality rate. Unfortunately, neither the etiology nor the pathophysiology of AP are fully understood and causal treatment options are not available. Recently we demonstrated that heparanase (Hpa) is adversely involved in the pathogenesis of AP and inhibition of this enzyme ameliorates the manifestation of the disease. Moreover, a pioneer study demonstrated that Aspirin has partial inhibitory effect on Hpa. Another compound, which possesses a mild pancreato‐protective effect against AP, is Trehalose, a common disaccharide. We hypothesized that combination of Aspirin, Trehalose, PG545 (Pixatimod) and SST0001 (Roneparstat), specific inhibitors of Hpa, may exert pancreato‐protective effect better than each drug alone. Thus, the current study examines the pancreato‐protective effects of Aspirin, Trehalose, PG545 and SST0001 in experimental model of AP induced by cerulein in wild‐type (WT) and Hpa over‐expressing (Hpa‐Tg) mice. Cerulein‐induced AP in WT mice was associated with significant rises in the serum levels of lipase (X4) and amylase (X3) with enhancement of pancreatic edema index, inflammatory response, and autophagy. Responses to cerulein were all more profound in Hpa‐Tg mice versus WT mice, evident by X7 and X5 folds increase in lipase and amylase levels, respectively. Treatment with Aspirin or Trehalose alone and even more so in combination with PG545 or SST0001 were highly effective, restoring the serum level of lipase back to the basal level. Importantly, a novel newly synthesized compound termed Aspirlose effectively ameliorated the pathogenesis of AP as a single agent. Collectively, the results strongly indicate that targeting Hpa by using anti‐Hpa drug combinations constitute a novel therapy for this common orphan disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, The Ruth & Bruce Rappaport Faculty of Medicine, Haifa, Israel.
- Department of Pathology, Carmel Hospital, Haifa, Israel.
- Department of Pathology, Rambam Health Care Center, Haifa, Israel.
- Department of Internal Medicine E, Rambam Health Care Center, Haifa, Israel.
- Department of Pharmacy, Rambam Health Care Center, Haifa, Israel.
- Department of Laboratory Medicine, Rambam Health Care Center, Haifa, Israel.
ORCID-Profile: Zaid Abassi
Förderung
- Israel Gastroenterology Association; and Kamin
Zitieren
APA
Hamo-Giladi, D. B., Fokra, A., Sabo, E., Kabala, A., Minkov, I., Hamoud, S., Hadad, S., Abassi, Z., & Khamaysi, I. (2024). Involvement of heparanase in the pathogenesis of acute pancreatitis: Implication of novel therapeutic approaches. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18512
Vancouver
Hamo-Giladi DB, Fokra A, Sabo E, Kabala A, Minkov I, Hamoud S, et al. Involvement of heparanase in the pathogenesis of acute pancreatitis: Implication of novel therapeutic approaches. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18512
BibTeX
@article{HamoGiladi2024,
author = {Hamo-Giladi, Dalit B and Fokra, Ahmad and Sabo, Edmond and Kabala, Aviva and Minkov, Irena and Hamoud, Shadi and Hadad, Salim and Abassi, Zaid and Khamaysi, Iyad},
title = {Involvement of heparanase in the pathogenesis of acute pancreatitis: Implication of novel therapeutic approaches},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18512}
}
EUVIMED